Higher-income countries are seeing their rates of premenopausal breast cancer increase faster, whereas cases of postmenopausal breast cancer are increasing in number faster in lower-income studies.
Higher-income countries are seeing their rates of premenopausal breast cancer increase faster, whereas cases of postmenopausal breast cancer are increasing in number faster in lower-income, but developing, countries, according to study results published recently in The Lancet Global Health.
“To our knowledge, this is the first study to investigate the global rates and trends of pre- and postmenopausal breast cancer,” said Miranda Fidler-Benaoudia, PhD, study principal investigator and member of the O’Brien Institute of Public Health at the Cumming School of Medicine in Calgary, Alberta, Canada, in a statement announcing the study results.
Their population-based analysis study, which investigated both incidence and mortality for pre- and postmenopausal breast cancer, comprised 44 patient populations from 41 countries (22 in Europe, 5 in North America, 10 in Asia, 1 in Africa, 4 in South America, 2 in Oceania), with trends assessed at 3 levels: national, local, and ethnic. Women who were postmenopausal were 50 years and older, while those premenopausal were younger than 50 years.
“We chose the cutoff point of 50 years because, internationally, the average age of natural menopause is 45-55 years, so we selected the mean of 50 years,” the authors noted.
Results show that overall cases of postmenopausal invasive breast cancer were diagnosed 53.9% more often than premenopausal breast cancer (645,000 vs 1,400,000, respectively), with 73.5% more deaths (130,000 vs 490,000).
The authors estimated trends in pre- and postmenopausal breast cancer for 1998 through 2012 with data from the International Agency for Research on Cancer’s (IARC) Cancer in Five Continents plus database and assessed their burden in 2018 with information from the IARC’s GLOBOCAN Cancer Today database.
In addition:
The authors suggest that the top reasons for the postmenopausal increase in developing countries is their adoption of a more Western lifestyle, including less physical activity, higher alcohol consumption, hormone-replacement therapy, and implementing screening for breast cancer. For the rise in premenopausal breast cancer, the authors note that reproductive decisions play a large part, chiefly having few, or no, children, and delaying childbirth to an older age, as well as earlier screening for breast cancer.
“We provide evidence of a rising burden of both premenopausal and postmenopausal breast cancer worldwide,” they concluded. “Although early diagnosis and access to treatment remain crucial in low-income and middle-income countries, primary prevention efforts seeking to decrease exposure to known breast cancer risk factors are warranted in all world regions to curb the future breast cancer burden.”
Reference
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8:e1027-e1037. doi:10.1016/S2214-109X(20)30215-1
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More